Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer’s disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, strongly correlating with established Alzheimer’s biomarkers from PET scans.
American Medical Association’s digital advisors table RPM coding reform proposal, again
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in